Profile
Christina Cognata-Smith is the founder and currently holds the position of Chief Scientific Officer at DAS Therapeutics, Inc. which is founded in 2019.
Christina Cognata-Smith active positions
Companies | Position | Start |
---|---|---|
DAS Therapeutics, Inc.
DAS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology DAS Therapeutics, Inc. is a clinical stage pharmaceutical company. It acquires and develops assets for conditions overlooked or under-served by current treatment approaches to improve patient outcomes. The company was founded by Raimonds Dzelme, Christina Cognata-Smith and Michael Nemmers in 2016 and is headquartered in Boston, MA. | Founder | 01/01/2019 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
DAS Therapeutics, Inc.
DAS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology DAS Therapeutics, Inc. is a clinical stage pharmaceutical company. It acquires and develops assets for conditions overlooked or under-served by current treatment approaches to improve patient outcomes. The company was founded by Raimonds Dzelme, Christina Cognata-Smith and Michael Nemmers in 2016 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Christina Cognata-Smith